Clinical Trial

Three Types of Nucleotide/Nucleoside Analogues Treatment in HBV Related ACLF

Study acronym: HBV
Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated November 29, 2024 (before its estimated December 31, 2024 completion). Its status may not reflect the trial's current state.
Summary
This study is to investigate the clinical efficacy of three types of nucleotide/nucleoside analogues in treatment of HBV-related acute-on-chronic liver failure.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2019-04-17.
Trial Details
NCT Number NCT03920618
Lead Sponsor Third Affiliated Hospital, Sun Yat-Sen University
Conditions Hepatitis B, Acute-On-Chronic Liver Failure
Enrollment 150 participants
Start Date 2019-02-21
Primary Completion 2024-12-31 (estimated)
Study Completion 2024-12-31 (estimated)
Updated on ClinicalTrials.gov 2024-11-29